References
- Matsuda K, Ogawa M, Murata A, Kitahara T, Kosaki G. Elevation of serum immunoreactive trypsin inhibitor contents in various malignant diseases. Res Comm Chem Pathol Pharmacol 1983; 40: 301–5
- Stenman U-H, Huhtala M-L, Koistinen R, Seppälä M. Immunochemical demonstration of an ovarian cancer-associated urinary peptide. Int J Cancer 1982; 30: 53–7
- Stenman U-H. Oral Communication at the Symposium. TATI in human pathology, Venice September 30th, 1987
- Lasson Å, Borgström A, Ohlsson K. Serum levels of immunoreactive PSTI in acute abdominal disorders, with special reference to a possible extrapancreatic production. Clin Chim Acta 1986; 161: 37–6
- Huhtala M-L, Kahanpää K, Seppälä M, Halila H, Stenman U-H. Excretion of a tumor-associated trypsin inhibitor (TATI) in urine of patients with gynaecological malignancy. Int J Cancer 1983; 31: 711–4
- Halila H, Huhtala M-L, Schröder T, Kiviluoto T, Stenman U-H. Pancreatic secretory trypsin inhibitor in pancreatectomized patients. Clin Chim Acta 1985; 153: 209–216
- Banfi G, Murone M, Slaviero G. High concentrations of tumor-associated trypsin inhibitor in hemodialyzed patients. Clin Chem 1988; 34: 174
- Pinching A J, Weiss RA. AIDS and spectrum of HTLV III-LAV infection. Int Rev Exp Path 1986; 28: 2–22